Antibodies Against Alzheimers Disease
A vaccine-based approach could be an effective therapy for people with mild or moderate form of Alzheimers disease. The medication used for this therapy will be tested at the Douglas Mental Health University Institute, participating in an international effort to find out more about the potential of this treatment. Most current therapies for Alzheimers treat the symptoms ociated with it and not the disease itself. The goal with this clinical trial is to explore if this investigational drug can help control the progression of Alzheimers by eliminating the protein that cause damage to the brain .
CARING.DISCOVERING.TEACHING. *** The Douglas is a world-class institute located in Montreal (Canada), affiliated with McGill University and the World Health Organization, which treats people suffering from mental illness and offers them hope and cure. Its teams of specialists and researchers continually advance scientific knowledge, integrate it into patient care, and share it with the community to increase awareness and thereby eliminate stigma around mental illness.
Duration : 0:1:4
After one year of successful treatment with sustained improvement, daughter discusses the value of perispinal etanercept for her mother and her family.
This movie describes the development of Alzheimer’s disease at a molecular level. It shows the very important role of the amyloid-beta peptides in the generation of deadly plaques in the brain. It is proposed by the research of professor Patrick C. Fraering who is head of the laboratory of Molecular and Cellular Biology of Alzheimer’s Disease at the Life Science department and Brain Mind Institute of the Swiss Federal Institute of Technology in Lausanne - EPFL. Professor Patrick Fraering’s lab website is at: http://fraering-lab.epfl.ch/ The graphics and sound engineering is done by the Visualbiotech team with help of its rendering and simulation system called BioInspire. Visualbiotech engineers: Music is composed by Kevin Macleod We hope you learned something new!